Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Breast Cancer

Free Subscription Articles published in Am J Surg Retrieve available abstracts of 41 articles: HTML format

Single Articles

February 2023
1. SUTTON TL, Patel R, Behrens S, Schwantes I, et al
   Delayed adjuvant endocrine therapy is associated with decreased recurrence-free survival following neoadjuvant chemotherapy for breast cancer.
   Am J Surg. 2023 Feb 24:S0002-9610(23)00088-0. doi: 10.1016/j.amjsurg.2023.
   PubMed     Abstract available
   
   
   
2. GELLINGS JA, Cortina CS, Jorns JM, Johnson MK, et al
   Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens.
   Am J Surg. 2023;225:304-308.
   PubMed     Abstract available
   
   
   January 2023
3. REYES A, Torregrosa L, Lozada-Martinez ID, Cabrera-Vargas LF, et al
   Breast cancer mortality research in Latin America: A gap needed to be filled.
   Am J Surg. 2023 Jan 12:S0002-9610(23)00009-0. doi: 10.1016/j.amjsurg.2023.
   PubMed    
   
   
   
4. ESTRADA J, Larson KE, Kilgore LJ, Wagner JL, et al
   Safety of de-escalation of surgical intervention for atypical ductal hyperplasia on percutaneous biopsy: One size does not fit all.
   Am J Surg. 2023;225:21-25.
   PubMed     Abstract available
   
   
   December 2022
5. DESHPANDE AJ, Bhandarkar A, Bobo WV, Bydon M, et al
   Examining the relationship between severe persistent mental illness and surgical outcomes in women undergoing mastectomy for breast cancer.
   Am J Surg. 2022 Dec 28:S0002-9610(22)00827-3. doi: 10.1016/j.amjsurg.2022.
   PubMed     Abstract available
   
   
   
6. ESPOSITO A, Ablah E, Okut H, Tenofsky PL, et al
   Characteristics, treatment and outcomes of HER2 positive male breast cancer.
   Am J Surg. 2022 Dec 9:S0002-9610(22)00791-7. doi: 10.1016/j.amjsurg.2022.
   PubMed     Abstract available
   
   
   
7. ELSHERIF A, Cocco D, Bernard S, Djohan R, et al
   Simultaneous contralateral prophylactic mastectomy compared to unilateral nipple-sparing mastectomy for breast cancer surgical treatment: Are complications higher?
   Am J Surg. 2022 Dec 7:S0002-9610(22)00789-9. doi: 10.1016/j.amjsurg.2022.
   PubMed     Abstract available
   
   
   
8. THOMPSON JL, Wright GP
   Contemporary approaches to the axilla in breast cancer.
   Am J Surg. 2022 Dec 5:S0002-9610(22)00776-0. doi: 10.1016/j.amjsurg.2022.
   PubMed     Abstract available
   
   
   
9. ZHANG C, Kosiorek H, Hammond JB, Jogerst KM, et al
   The impact of mastectomy and reconstruction technique on patient perceived quality of Life.
   Am J Surg. 2022;224:1450-1454.
   PubMed     Abstract available
   
   
   November 2022
10. VALENTE SA, ElSherif A, Tran J, Tu C, et al
    Inflammatory breast cancer and the importance of skin punch biopsy.
    Am J Surg. 2022 Nov 12:S0002-9610(22)00727-9. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    
11. KANDI LA, Hammond JB, Thornburg DA, Jarvis TL, et al
    Can Montgomery tubercles impact aesthetic 3D nipple-areolar complex tattooing? An anatomical, quantitative analysis of breast cancer patients.
    Am J Surg. 2022 Nov 9:S0002-9610(22)00714-0. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    October 2022
12. KO G, Sequeira S, McCready DR, Sarvanantham S, et al
    Utilization of a rapid diagnostic centre during the COVID-19 pandemic reduced diagnostic delays in breast cancer.
    Am J Surg. 2022 Oct 3. pii: S0002-9610(22)00621.
    PubMed     Abstract available
    
    
    
13. CHENG D, Baynosa J, Cross C, Kirgan D, et al
    Comparing the effect of distance to treatment facility on reconstruction and breast conservation therapy for early-stage invasive ductal carcinoma between the nation and the mountain region.
    Am J Surg. 2022;224:1049-1056.
    PubMed     Abstract available
    
    
    September 2022
14. SINGH R, Cao L, Sarode AL, Kharouta M, et al
    Trends in surgery and survival for T1-T2 male breast cancer: A study from the National Cancer Database.
    Am J Surg. 2022 Sep 25. pii: S0002-9610(22)00592.
    PubMed     Abstract available
    
    
    
15. ROONEY MM, Thomas SM, Taskindoust M, Greenup RA, et al
    The role of tumor phenotype in the surgical treatment of early-stage breast cancer.
    Am J Surg. 2022 Sep 22. pii: S0002-9610(22)00576.
    PubMed     Abstract available
    
    
    
16. JATANA S, Zahra S, Miron AD, Antonacci G, et al
    A retrospective study evaluating outcomes of surgical excision versus radiologic follow-up of benign breast papillomas without atypia.
    Am J Surg. 2022;224:932-937.
    PubMed     Abstract available
    
    
    
17. MOHAN SC, Siegel E, Tran H, Ozcan L, et al
    Effects of paravertebral blocks versus liposomal bupivacaine on hospital utilization after mastectomy with reconstruction.
    Am J Surg. 2022;224:938-942.
    PubMed     Abstract available
    
    
    August 2022
18. NNOROM SO, Akinyemi O, Tran J, Baig H, et al
    Color or money?: The impact of socioeconomic status and race/ethnicity on breast cancer mortality.
    Am J Surg. 2022 Aug 24. pii: S0002-9610(22)00456.
    PubMed     Abstract available
    
    
    
19. AZIN A, Tahmasebi H, Brar A, Azin S, et al
    Racial, ethnic and socioeconomic disparities in diagnosis, treatment, and survival of patients with breast cancer.
    Am J Surg. 2022 Aug 5. pii: S0002-9610(22)00448.
    PubMed     Abstract available
    
    
    
20. KRIPALANI S, Kulshreshta S, Saracco B, Meterissian S, et al
    The effect of COVID-19 on breast cancer care and treatment in North America: A scoping review.
    Am J Surg. 2022 Aug 3. pii: S0002-9610(22)00460.
    PubMed     Abstract available
    
    
    
21. WETZEL CL, Gardiner SK, Johnson N, Garreau JR, et al
    Variation in adoption of skin and nipple sparing mastectomy: An opportunity to enhance patient outcomes.
    Am J Surg. 2022;224:710-715.
    PubMed     Abstract available
    
    
    
22. BALISKI C, Bakos B
    Patient reported outcomes following breast conserving surgery are improved by minimizing re-excisions and excessive breast tissue removal.
    Am J Surg. 2022;224:716-721.
    PubMed     Abstract available
    
    
    July 2022
23. HAMMOND JB, Foley BM, Kosiorek HE, Cronin PA, et al
    Seldom one and done: Characterizing rates of reoperation with direct-to-implant breast reconstruction after mastectomy.
    Am J Surg. 2022;224.
    PubMed     Abstract available
    
    
    May 2022
24. FASANO GA, Bayard S, Tamimi R, Bea V, et al
    Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City.
    Am J Surg. 2022 May 27. pii: S0002-9610(22)00391.
    PubMed     Abstract available
    
    
    
25. KHUBCHANDANI JA, Greenup RA
    Time to surgery delays: Barriers to care for black women with breast cancer.
    Am J Surg. 2022 May 21. pii: S0002-9610(22)00308.
    PubMed    
    
    
    
26. FAYANJU OM, Fieber JH
    Redressing breast cancer screening disparities during the COVID-19 pandemic: Turning crisis into opportunity.
    Am J Surg. 2022 May 14. pii: S0002-9610(22)00309.
    PubMed    
    
    
    April 2022
27. HEWITT KC, Miller P, Piper M, Prionas N, et al
    Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.
    Am J Surg. 2022;223:699-704.
    PubMed     Abstract available
    
    
    March 2022
28. KAPUR H, Bazzarelli A, Warburton R, Pao JS, et al
    Accuracy of preoperative imaging estimates: Opportunities to de-escalate surgery for early invasive breast cancer.
    Am J Surg. 2022 Mar 31. pii: S0002-9610(22)00232.
    PubMed     Abstract available
    
    
    
29. 
    Trends of contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg. 2022;223:538.
    PubMed    
    
    
    
30. KELLY-SCHUETTE KA, Wempe K, Fritz GD, Hop A, et al
    Masculinizing chest surgery for gender affirmation: A retrospective study of outcomes and patient reported satisfaction.
    Am J Surg. 2022;223:577-580.
    PubMed     Abstract available
    
    
    
31. ELSHERIF A, Armanyous S, Gentle CK, Al-Hilli Z, et al
    Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg. 2022;223:533-537.
    PubMed     Abstract available
    
    
    February 2022
32. ELSHERIF A, Armanyous S, Valente S
    Mastectomy options for the treatment of breast cancer recurrence after lumpectomy.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00083.
    PubMed    
    
    
    
33. SARGENT RE, Vazquez E, Kang I, Lu J, et al
    Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00084.
    PubMed    
    
    
    
34. CROWN A, Buchanan C
    My surgical practice: Presenting aesthetic flat closure as an equal option to mastectomy with reconstruction and technical considerations to optimize cosmesis.
    Am J Surg. 2022;223:436-437.
    PubMed    
    
    
    January 2022
35. JOSEPH KA
    Addressing breast cancer surgical disparities using a community-clinical linkage patient navigation model strategy in a NYC hospital system.
    Am J Surg. 2022 Jan 22. pii: S0002-9610(22)00015.
    PubMed    
    
    
    
36. JAIN U, Jain B, Fayanju OM, Chino F, et al
    Disparities in timely treatment among young women with breast cancer.
    Am J Surg. 2022 Jan 22. pii: S0002-9610(22)00020.
    PubMed     Abstract available
    
    
    
37. BECK AC, Fu SL, Liao J, Bashir A, et al
    Risk management recommendations and patient acceptance vary with high-risk breast lesions.
    Am J Surg. 2022;223:94-100.
    PubMed     Abstract available
    
    
    December 2021
38. ELSHERIF A, Armanyous S, Al-Hilli Z, Valente SA, et al
    Mastectomy options for the treatment of ipsilateral breast cancer recurrence after lumpectomy.
    Am J Surg. 2021 Dec 15. pii: S0002-9610(21)00713.
    PubMed     Abstract available
    
    
    November 2021
39. SARGENT RE, Vazquez E, Kang I, Lu J, et al
    Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center.
    Am J Surg. 2021 Nov 16. pii: S0002-9610(21)00676.
    PubMed     Abstract available
    
    
    October 2021
40. CHAGPAR AB, Dupont E, Chiba A, Levine EA, et al
    Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients.
    Am J Surg. 2021 Oct 23. pii: S0002-9610(21)00620.
    PubMed     Abstract available
    
    
    
41. MANDELBAUM A, Nakhla M, Seo YJ, Dobaria V, et al
    National trends and predictors of mastectomy with immediate breast reconstruction.
    Am J Surg. 2021;222:773-779.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: